A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.
about
IVIG regulates the survival of human but not mouse neutrophils.On the dark side of therapies with immunoglobulin concentrates: the adverse eventsSingle-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsThe lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacementThe protective role of immunoglobulins in fungal infections and inflammation.Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.IVIG-mediated effector functions in autoimmune and inflammatory diseases.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.The effect of Intravenous Immunoglobulin (IVIG) on \textit{ex vivo} activation of human leukocytes.A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin.Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation.Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
P2860
Q33683531-26826550-1B1B-4CDA-957B-52D38D6FDC31Q35053458-DEAA2CEA-78F5-40B1-B28B-535528667B06Q35537053-6F816B69-8186-4EA2-A598-A99AA67E3982Q36216197-9ABDF5D9-FF70-4EDA-BC21-832CF8C7EDAEQ36350848-92C03BAF-E6B9-4D68-B68C-4CD9EBEA93BAQ38268922-F31EA26B-25E4-416D-82D7-C9C20F5171ADQ38310244-15B5534B-A038-4D9A-B6A0-F3648A539FABQ38697505-C5EEA81C-5C90-495B-81B3-5DDD5E19466FQ38699812-19BEB618-E567-4BAF-BCFF-4355F344A837Q38820288-0E980F52-CBAE-4DD1-BB9C-B6DB48362474Q38995599-008253E0-0259-4210-B82E-54C29B5F29BDQ40133456-41FE6A8C-697C-41D9-8265-0473396352A5Q41290101-5C05386E-3587-484F-AA62-5B267331D92DQ45422267-8036B67B-4685-48E7-AC8A-3A29D6E7F5B4Q46872401-764E4BB1-747C-4544-BA15-9297A4DA8231Q55029078-AD57958D-228C-4138-B050-7077AC992109Q58861212-E1F594A9-2779-4987-8B3D-12A101A3302F
P2860
A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A differential concentration-d ...... anti-inflammatory mechanisms.
@ast
A differential concentration-d ...... anti-inflammatory mechanisms.
@en
type
label
A differential concentration-d ...... anti-inflammatory mechanisms.
@ast
A differential concentration-d ...... anti-inflammatory mechanisms.
@en
prefLabel
A differential concentration-d ...... anti-inflammatory mechanisms.
@ast
A differential concentration-d ...... anti-inflammatory mechanisms.
@en
P2093
P2860
P50
P1433
P1476
A differential concentration-d ...... anti-inflammatory mechanisms.
@en
P2093
Carole Elbim
Jean-Luc Teillaud
Lakhdar Fattoum
Sarah Casulli
Selma Topçu
P2860
P304
P356
10.1371/JOURNAL.PONE.0026469
P407
P577
2011-10-31T00:00:00Z